| KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA … AC Garcia-Montero, M Jara-Acevedo, C Teodosio, ML Sanchez, R Nunez, ... Blood 108 (7), 2366-2372, 2006 | 576 | 2006 |
| Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients L Escribano, I Álvarez-Twose, L Sánchez-Muñoz, A Garcia-Montero, ... Journal of allergy and clinical immunology 124 (3), 514-521, 2009 | 312 | 2009 |
| Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms I Álvarez-Twose, DG de Olano, L Sánchez-Muñoz, A Matito, ... Journal of allergy and clinical immunology 125 (6), 1269-1278. e2, 2010 | 276 | 2010 |
| Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis I Alvarez‐Twose, S Vañó‐Galván, L Sánchez‐Muñoz, JM Morgado, ... Allergy 67 (6), 813-821, 2012 | 186 | 2012 |
| Validation of the REMA score for predicting mast cell clonality and systemic mastocytosis in patients with systemic mast cell activation symptoms I Alvarez-Twose, D Gonzalez-de-Olano, L Sánchez-Muñoz, A Matito, ... International archives of allergy and immunology 157 (3), 275-280, 2012 | 157 | 2012 |
| Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis DG De Olano, I Álvarez-Twose, MI Esteban-López, L Sánchez-Muñoz, ... Journal of allergy and clinical immunology 121 (2), 519-526, 2008 | 148 | 2008 |
| Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes C Teodosio, AC García-Montero, M Jara-Acevedo, L Sánchez-Muñoz, ... Journal of Allergy and Clinical Immunology 125 (3), 719-726. e4, 2010 | 147 | 2010 |
| Human small-intestinal epithelium contains functional natural killer lymphocytes F León, E Roldán, L Sanchez, C Camarero, A Bootello, G Roy Gastroenterology 125 (2), 345-356, 2003 | 142 | 2003 |
| Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM I Álvarez-Twose, R Zanotti, D González-de-Olano, P Bonadonna, A Vega, ... Journal of allergy and clinical immunology 133 (2), 520-528. e5, 2014 | 140 | 2014 |
| Generation of anaphylatoxins by human β-tryptase from C3, C4, and C5 Y Fukuoka, HZ Xia, LB Sanchez-Munoz, AL Dellinger, L Escribano, ... The Journal of Immunology 180 (9), 6307-6316, 2008 | 124 | 2008 |
| Evaluation of the WHO criteria for the classification of patients with mastocytosis L Sánchez-Muñoz, I Alvarez-Twose, AC García-Montero, C Teodosio, ... Modern Pathology 24 (9), 1157-1168, 2011 | 115 | 2011 |
| Venom immunotherapy in patients with clonal mast cell disorders: efficacy, safety, and practical considerations P Bonadonna, D Gonzalez-de-Olano, R Zanotti, A Riccio, L De Ferrari, ... The Journal of Allergy and Clinical Immunology: In Practice 1 (5), 474-478, 2013 | 110 | 2013 |
| Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications M Jara-Acevedo, C Teodosio, L Sanchez-Muñoz, I Álvarez-Twose, ... Modern Pathology 28 (8), 1138-1149, 2015 | 103 | 2015 |
| Anti-transglutaminase IgA ELISA: clinical potential and drawbacks in celiac disease diagnosis F Leon, C Camarero, R R-Pena, P Eiras, L Sanchez, M Baragano, ... Scandinavian journal of gastroenterology 36 (8), 849-853, 2001 | 103 | 2001 |
| Susceptibility of different leukocyte cell types to Vaccinia virus infection JM Sánchez-Puig, L Sánchez, G Roy, R Blasco Virology journal 1, 1-7, 2004 | 100 | 2004 |
| Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis I Álvarez-Twose, M Jara-Acevedo, JM Morgado, A García-Montero, ... Journal of Allergy and Clinical Immunology 137 (1), 168-178. e1, 2016 | 97 | 2016 |
| Imatinib in systemic mastocytosis: a phase IV clinical trial in patients lacking exon 17 KIT mutations and review of the literature I Alvarez-Twose, A Matito, JM Morgado, L Sánchez-Muñoz, ... Oncotarget 8 (40), 68950, 2017 | 95 | 2017 |
| CD 30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis JM Morgado, O Perbellini, RC Johnson, C Teodósio, A Matito, ... Histopathology 63 (6), 780-787, 2013 | 92 | 2013 |
| Dermoscopic features of skin lesions in patients with mastocytosis S Vano-Galvan, I án Álvarez-Twose, E De las Heras, JM Morgado, ... Archives of dermatology 147 (8), 932-940, 2011 | 91 | 2011 |
| Immunophenotyping in systemic mastocytosis diagnosis:‘CD25 positive'alone is more informative than the ‘CD25 and/or CD2'WHO criterion JMT Morgado, L Sánchez-Munoz, CG Teodosio, M Jara-Acevedo, ... Modern Pathology 25 (4), 516-521, 2012 | 86 | 2012 |
Luis EscribanoAssociated Researcher, Universidad de SalamancaVerified email at usal.es
